Mapping uncertainty in genomics
暂无分享,去创建一个
[1] A. McGuire,et al. Informed consent in genomics and genetic research. , 2010, Annual review of genomics and human genetics.
[2] C R Scriver,et al. Monogenic traits are not simple: lessons from phenylketonuria. , 1999, Trends in genetics : TIG.
[3] Sandi Dheensa,et al. Defining and managing incidental findings in genetic and genomic practice , 2014, Journal of Medical Genetics.
[4] M. Bamshad,et al. Genomics really gets personal: How exome and whole genome sequencing challenge the ethical framework of human genetics research , 2011, American journal of medical genetics. Part A.
[5] H. Howard,et al. Ethical issues raised by whole genome sequencing. , 2014, Best practice & research. Clinical gastroenterology.
[6] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[7] Rena A. Godfrey,et al. The implications of familial incidental findings from exome sequencing: The NIH Undiagnosed Diseases Program experience , 2014, Genetics in Medicine.
[8] Ortwin Renn,et al. A New Approach to Risk Evaluation and Management: Risk‐Based, Precaution‐Based, and Discourse‐Based Strategies 1 , 2002, Risk analysis : an official publication of the Society for Risk Analysis.
[9] Christian Gilissen,et al. Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.
[10] Paul K J Han,et al. Varieties of uncertainty in health care: a conceptual taxonomy. , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] A. Cambon-Thomsen,et al. The Ethical Introduction of Genome-Based Information and Technologies into Public Health , 2013, Public Health Genomics.
[12] Paul K. J. Han,et al. Varieties of Uncertainty in Health Care , 2011 .
[13] W. Klein,et al. How do research participants perceive “uncertainty” in genomic sequencing? , 2014, Genetics in Medicine.
[14] Jorge Sequeiros,et al. Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing , 2009, European Journal of Human Genetics.
[15] Emily H Turner,et al. Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.
[16] J. Roberts,et al. Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues , 2013, Progress in Neurobiology.
[17] P. Baptista. Principles in genetic risk assessment , 2005, Therapeutics and clinical risk management.
[18] J. Millán,et al. Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process , 2013, European Journal of Human Genetics.
[19] J. Bell. Predicting disease using genomics , 2004, Nature.
[20] So rare we need to hunt for them: reframing the ethical debate on incidental findings , 2015, Genome Medicine.
[21] B. Solomon. Obstacles and opportunities for the future of genomic medicine , 2014, Molecular genetics & genomic medicine.
[22] A M Kellerer,et al. Risk perception , 1993, Nature.
[23] Paul K J Han,et al. Conceptual, Methodological, and Ethical Problems in Communicating Uncertainty in Clinical Evidence , 2013, Medical care research and review : MCRR.